Alnylam

Alnylam, Medtronic RNAi drug-device combo wows with preclinical data
Fierce Drug Delivery
Fri, 12/30/11 - 11:36 am
Alnylam
Medtronic
Device
RNAi
A Step Forward for RNA Interference
NY Times, NY
Mon, 11/21/11 - 01:02 pm
Alnylam
RNA interference
RNAi
Biotech Takeovers Could Heat Up These Stocks
Seeking Alpha
Fri, 11/18/11 - 11:47 am
M&A
Acorda
Alnylam
Adolor
Cubist
Chelsea Therapeutics
Catalyst
Human Genome Sciences
3 Cancer Immunotherapy Biotechs With Catalysts For 2012
Seeking Alpha
Thu, 11/17/11 - 09:03 am
Alnylam
Dendreon
GSK
Medivation
ImmunoCellular
Novartis
cancer
NewLink Genetics
4 Biotech Stocks Predictive Analysts Expect To Underperform
Seeking Alpha
Mon, 11/14/11 - 05:25 pm
Dendreon
Seattle Genetics
Sunesis
Alnylam
9 Biotech Stocks Trading At Steepest Discount To Target Price
Seeking Alpha
Sun, 10/30/11 - 12:40 pm
Inhibitex
Affymax
Alnylam
Incyte
Ziopharm
Array Biopharma
Ariad Pharmaceuticals
Xoma
Complete Genomics
3 Biotech Takeover/LBO Targets With Bullish Short Trends
Seeking Alpha
Wed, 10/26/11 - 10:25 am
M&A
Alnylam
Seattle Genetics
Exelixis
Next big drug against cholesterol takes shape
HealthNews
Sat, 08/27/11 - 01:35 pm
Regeneron
Sanofi
hypercholesterolemia
PCSK9
Amgen
Merck
Alnylam
Bristol-Myers Squibb
REGN727
Alnylam narrows loss on lower costs
Bizjournals.com
Tue, 08/2/11 - 12:26 pm
earnings
Alnylam
4 Biotech Companies Reporting Earnings Next Week With Recent Winning Streaks
Seeking Alpha
Sat, 07/30/11 - 09:46 am
Ariad Pharmaceuticals
NPS Pharmaceuticals
Immunogen
Alnylam
9 Small Biotechs Near 52-Week Lows
Motley Fool
Sat, 07/23/11 - 03:11 pm
MannKind
Alnylam
Theratechnologies
Metabolix
Cell Therapeutics
Novavax
AVI BioPharma
Allos
Vanda
10 Biotech Takeover/LBO Targets With Bullish Options Sentiment
Seeking Alpha
Thu, 07/21/11 - 12:21 pm
M&A
Chelsea Therapeutics
Amgen
Human Genome Sciences
Acorda Therapeutics
Celgene
Dendreon
InterMune
Biomarin
Alnylam
Exelixis
Alnylam Presents Phase I Data for ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancers, at American Society of Clinical Oncology (ASCO) Meeting
Yahoo/BusinessWire
Sun, 06/5/11 - 10:04 am
Alnylam
liver cancer
ALN-VSP
RNAi
7 Dirt-Cheap Takeover Targets in Biotech
Seeking Alpha
Fri, 06/3/11 - 10:44 am
M&A
Acorda Therapeutics
Antares
Alnylam
BioSante
Catalyst
Inhibitex
Keryx
The Biggest Gift Biotechs Can Give to Investors
Motley Fool
Tue, 05/31/11 - 12:36 pm
investors
biotech
Vertex Pharmaceuticals
Exelixis
CytRx
GSK
Novavax
JNJ
Pfizer
Biogen Idec
Seattle Genetics
Immunogen
Alnylam
Battered but Unbroken Biotechs
Seeking Alpha
Tue, 03/1/11 - 10:26 am
Amylin
Alnylam
Celldex
Exelixis
Human Genome Sciences
Isis Pharmaceuticals
Lexicon Pharmaceuticals
Neurocrine
Nektar
ONYX Pharmaceuticals
Ziopharm
Seattle Genetics
Time to Buy Into Stem Cells?
Motley Fool
Tue, 02/1/11 - 08:23 am
stem cells
Geron
Neuralstem
StemCells
Pfizer
GSK
Cephalon
Mesoblast
Merck
Alnylam
Deals to Be Done After AstraZeneca Setback
WSJ Online
Thu, 12/23/10 - 08:26 am
AstraZeneca
RSV
Cubist Pharmaceuticals
NanoBio
MicroDose Therapeutx
Novavax
Synagis
motavizumab
Alnylam
Alnylam says it won Europe RNA patent dispute
Yahoo/AP
Fri, 12/3/10 - 06:44 am
patents
Alnylam
RNA
gene silencing
Merck
Pfizer
Sima
RNAi Is On Sale
Motley Fool
Tue, 11/30/10 - 10:52 am
RNAi
Merck
Alnylam
Pfizer
Amgen
Novartis
Eli Lilly
Roche

Pages